Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.

Details

Language :

English

ISSN :

0732183X

Volume :

27

Issue :

15

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105534587

Full Text :

https://doi.org/10.1200/JCO.2008.19.9356